Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0000899243-22-006413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | CGEM | Savill Corrine | Acting Chief Business Off | A - Grant | $0.00 | +16.5K | 209.6K | +9% | $0 |
| D | 2022-02-15 | 2022-02-11 | CGEM | Savill Corrine | Acting Chief Business Off | A - Grant | $0.00 | +33.0K | 33.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | A | A | 16,500 | $0.00 | 209,615 | D | — | — | (F1) The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-11 | A | A | 33,000 | $0.00 | 33,000 | D | $13.60 · — to 2032-02-10 | 33,000 Common Stock | (F2) The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date. |